Gene · 7423
Papers4,111
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,111
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ARHGAP17 and VEGFB as Biomarkers for Electroacupuncture in Rheumatoid Arthritis: Potential and Unresolved Questions [Letter]. | J Pain Res | 2025 | 41268064 | PubTator, text mining | PubMed |
| Serum Behavior of NT-3 and VEGFβ, Two Unstudied Growth Factors in Patients with Diabetes Mellitus and End-Stage Renal Disease. | J Clin Med | 2025 | 41226982 | PubTator, text mining | PubMed |
| VEGFB is a potential therapeutic target for Alzheimer's disease: Insights from integrative multi-omics analysis. | J Alzheimers Dis | 2025 | 41105597 | PubTator, text mining | PubMed |
| Advances in Molecular and Translational Medicine: 2nd Edition. | Int J Mol Sci | 2025 | 41096897 | PubTator, text mining | PubMed |
| Predictive Value of Serum VEGF Levels in Non-Small Cell Lung Cancer: A Review. | Oncol Res | 2025 | 41050088 | PubTator, text mining | PubMed |
| Modulation of prostaglandin-endoperoxide synthase-2 (PTGS2) mediated VEGF-signalling pathway by oral metronomic chemotherapy in locally advanced oral squamous cell Carcinoma: A brief report. | Cancer Chemother Pharmacol | 2025 | 41045400 | PubTator, text mining | PubMed |
| Characterisation of the expression of P2X7 receptor, cancer stem cell markers and immunological mediators in human high-grade gliomas. | BMC Neurosci | 2025 | 41034696 | PubTator, text mining | PubMed |
| Characterization of anticancer therapy-induced microvascular dysfunction in patients with breast cancer supports targeted intervention. | JCI Insight | 2025 | 41026534 | PubTator, text mining | PubMed |
| Visfatin Modulates Angiogenesis and Apoptosis in Porcine Luteal Cells via INSR, MAPK, and AKT Pathways. | Mol Reprod Dev | 2025 | 41015905 | PubTator, text mining | PubMed |
| Molecular Signatures Related to Inflammation and Angiogenesis in Patients with Lower Extremity Artery Disease, Abdominal Aortic Aneurysm, and Varicose Veins: Shared and Distinct Pathways. | Int J Mol Sci | 2025 | 41009355 | PubTator, text mining | PubMed |
| Efficacy of Intravitreal Brolucizumab for Chronic Central Serous Chorioretinopathy: A Pilot Study. | J Pers Med | 2025 | 41003112 | PubTator, text mining | PubMed |
| Deciphering the Role of Different Ceramide Synthases in the Human Cardiomyocyte Hypertrophic Response. | Metabolites | 2025 | 41003018 | PubTator, text mining | PubMed |
| Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications. | Curr Oncol | 2025 | 41002582 | PubTator, text mining | PubMed |
| SH3BP5-driven metabolic-immune crosstalk in DLBCL: a prognostic biomarker and therapeutic target for reshaping immunosuppressive microenvironment. | J Transl Med | 2025 | 40993727 | PubTator, text mining | PubMed |
| Tumour Single-Cell Bioinformatics: From Immune Profiling to Molecular Dynamics. | J Cell Mol Med | 2025 | 40954554 | PubTator, text mining | PubMed |
| ECM-based molecular subtypes define prognostic, EMT status, and therapeutic diversity in IDH-mutant gliomas. | NPJ Precis Oncol | 2025 | 40866630 | PubTator, text mining | PubMed |
| Holistic regulation of the diabetic osteo-microenvironment via NIR-II nanocarriers with dual NO/pH responsiveness for enhanced bone regeneration. | Bioact Mater | 2025 | 40860012 | PubTator, text mining | PubMed |
| Exosomes derived from mesenchymal stem cells mediate miR-218 and inhibit proliferation, migration, and oxidative stress in retinal vascular endothelial cells via the EGFR/Akt/mTOR signaling pathway. | Medicine (Baltimore) | 2025 | 40859585 | PubTator, text mining | PubMed |
| Integrating bulk and single-cell RNA data with machine learning to explore mitophagy in periodontitis. | Medicine (Baltimore) | 2025 | 40859550 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps in tumor metastasis: mechanisms, and therapeutic implications. | Discov Oncol | 2025 | 40858985 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7423/papers?page=4